Personalized GLP-1 Injectable

Personalized GLP-1 Injectable

Compounded GLP-1 Therapy (Semaglutide)

Semaglutide is a GLP-1 receptor agonist that works on appetite-regulation pathways in the body. This once-weekly compounded injectable is available following an online medical consultation, with dosing determined and adjusted by a licensed provider based on your individual evaluation.

$99 for the first month, $159 thereafter


Provider-supervised titration and follow-ups throughout treatment.

Personalized plan, not a one-size-fits-all dose — your provider titrates based on your response.

Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality.

Medication shipped monthly directly from a U.S.-licensed pharmacy.

How it Works

Complete a private online intake, get reviewed by a licensed provider, and receive your personalized plan — shipped monthly from a U.S.-licensed pharmacy.

WHAT PEOPLE ARE SAYING

“The findings of this study represent a major breakthrough for improving the health of people with obesity.”

— Professor Rachel Batterham, University College London, principal author of the STEP 1 semaglutide trial (New England Journal of Medicine). Individual results may vary.

FREQUENTLY ASKED QUESTIONS